Clinical Trials Related to Advanced Cancer

Related studies linked through entity extraction aliases.

A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1

Oncology Associated Symptoms & Individualized Strategies

Status: WITHDRAWN
Phase: NA

Study of Amblyomin-X in Advanced Solid Tumor

Status: SUSPENDED
Phase: PHASE1

First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1/PHASE2

A Study of AGEN2034 in Advanced Tumors and Cervical Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial

Status: WITHDRAWN
Phase: PHASE2

A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics

Status: UNKNOWN
Phase: PHASE1

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Status: COMPLETED
Phase: PHASE1/PHASE2

Quality of Life Intervention for Patients Receiving Radiation Therapy for Advanced Cancer Treatment and Their Caregivers

Status: COMPLETED
Phase: NA

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

Status: COMPLETED
Phase: N/A

Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers

Status: COMPLETED
Phase: NA

PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies

Status: UNKNOWN
Phase: PHASE1/PHASE2

Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer

Status: COMPLETED
Phase: PHASE1

A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics

Status: UNKNOWN
Phase: PHASE1

A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)

Status: COMPLETED
Phase: PHASE1

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Status: UNKNOWN
Phase: PHASE3

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

Status: TERMINATED
Phase: PHASE2

A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics

Status: UNKNOWN
Phase: PHASE1

A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma

Status: COMPLETED
Phase: PHASE2